# ğ™¿ğš‘ğšŠğš›ğš–ğšŠğšŒğšğšğšğš’ğšŒğšŠğš• ğ™¼ğšŠğš›ğš”ğšğš ğ™°ğš—ğšŠğš•ğš¢ğšœğš’ğšœ - ğ˜‰ğ‘ğ˜¯ğ‘”ğ˜­ğ‘ğ˜¥ğ‘’ğ˜´â„ ğºğ˜¦ğ‘›ğ˜¦ğ‘Ÿğ˜ªğ‘ ğ‘€ğ˜¦ğ‘‘ğ˜ªğ‘ğ˜ªğ‘›ğ˜¦ ğ˜”ğ‘ğ˜³ğ‘˜ğ˜¦ğ‘¡

# ğ™‹ğ’“ğ™¤ğ’‹ğ™šğ’„ğ™© ğ™Šğ’—ğ™šğ’“ğ™«ğ’Šğ™šğ’˜

This project provides an in-depth analysis of the Bangladesh Generic Medicine Market using a comprehensive dataset comprising information on medicine brands, generics, manufacturers, drug classes, and dosage forms. The primary goal is to uncover key trends, pricing structures, competition dynamics, and market segments using Power BI for data visualization. This analysis will be beneficial for pharmaceutical companies, healthcare professionals, policymakers, and researchers to make data-driven decisions and improve access to affordable medicines.


# ğ‘«ğ™–ğ’•ğ™–ğ’”ğ™šğ’•ğ™¨ ğ™ğ’”ğ™šğ’…

The project leverages six datasets to deliver a comprehensive analysis:

ğ¦ğğğ¢ğœğ¢ğ§ğ.ğœğ¬ğ¯:
Contains data on medicine brands, dosages, prices, and associated generic names.

ğ¦ğšğ§ğ®ğŸğšğœğ­ğ®ğ«ğğ«.ğœğ¬ğ¯:
Provides details on pharmaceutical manufacturers, including their unique IDs, locations, and production capacities.

ğ¢ğ§ğğ¢ğœğšğ­ğ¢ğ¨ğ§.ğœğ¬ğ¯:
Captures data on medical indications associated with different medicines, helping analyze the therapeutic applications.

ğ ğğ§ğğ«ğ¢ğœ.ğœğ¬ğ¯:
Includes the generic names of drugs, dosage information, and market presence.

ğğ«ğ®ğ _ğœğ¥ğšğ¬ğ¬.ğœğ¬ğ¯:
Lists the drug classifications, therapeutic categories, and chemical classes for a broad view of the market composition.

ğğ¨ğ¬ğšğ ğ_ğŸğ¨ğ«ğ¦.ğœğ¬ğ¯:
Defines various dosage forms like tablets, injections, syrups, and their corresponding formulations.

# ğ‘´ğ™šğ’•ğ™ğ’ğ™™ğ’ğ™¡ğ’ğ™œğ’š

ğŸ­. ğ——ğ—®ğ˜ğ—® ğ—–ğ—¹ğ—²ğ—®ğ—»ğ—¶ğ—»ğ—´

Addressed missing values, removed duplicate records, and ensured consistent formatting.
Standardized units for dosages (e.g., mg, mL, IU) to make comparisons easier across different medicines.

ğŸ®. ğ——ğ—®ğ˜ğ—® ğ— ğ—¼ğ—±ğ—²ğ—¹ğ—¶ğ—»ğ—´

Established relationships between the tables by creating key links such as manufacturer_id between medicine.csv and manufacturer.csv, and generic drug names between medicine.csv and generic.csv.
Built a star schema model to facilitate efficient querying and reporting in Power BI.

ğŸ¯. ğ—˜ğ˜…ğ—½ğ—¹ğ—¼ğ—¿ğ—®ğ˜ğ—¼ğ—¿ğ˜† ğ——ğ—®ğ˜ğ—® ğ—”ğ—»ğ—®ğ—¹ğ˜†ğ˜€ğ—¶ğ˜€ (ğ—˜ğ——ğ—”)

Analyzed pricing patterns by manufacturer, drug class, and dosage form.
Explored the distribution of medicines across different therapeutic areas and identified top manufacturers and drug categories.

ğŸ°. ğ—©ğ—¶ğ˜€ğ˜‚ğ—®ğ—¹ğ—¶ğ˜‡ğ—®ğ˜ğ—¶ğ—¼ğ—»ğ˜€ ğ—®ğ—»ğ—± ğ——ğ—®ğ˜€ğ—µğ—¯ğ—¼ğ—®ğ—¿ğ—±

Developed an interactive Power BI dashboard showcasing market overviews, top players, competition levels, pricing trends, and regional disparities in drug availability.

# ğ™†ğ’†ğ™® ğ™„ğ’ğ™¨ğ’Šğ™œğ’‰ğ™©ğ’”

ğ— ğ—®ğ—¿ğ—¸ğ—²ğ˜ ğ—–ğ—¼ğ—ºğ—½ğ—¼ğ˜€ğ—¶ğ˜ğ—¶ğ—¼ğ—»:

The dataset reveals that there are 21,714 medicine brands, 1,711 generics, 240 manufacturers, 453 drug classes, and 113 dosage forms available in the market.
Cardiovascular drugs and diabetes treatments dominate the market due to the prevalence of chronic diseases in the country.

ğ—Ÿğ—²ğ—®ğ—±ğ—¶ğ—»ğ—´ ğ—£ğ—¹ğ—®ğ˜†ğ—²ğ—¿ğ˜€:

Incept Pharmaceuticals Ltd. emerges as the top manufacturer with the highest number of drugs in the market, followed by Square Pharmaceuticals Ltd. and Beximco Pharmaceuticals Ltd..
Cefixime trihydrate is the most frequently produced generic, with widespread use in antibiotics.

ğ—£ğ—¿ğ—¶ğ—°ğ—¶ğ—»ğ—´ ğ—§ğ—¿ğ—²ğ—»ğ—±ğ˜€:

Significant pricing differences exist between locally manufactured generics and imported ones, with local drugs being more affordable.
Highly competitive categories like anti-hypertensive medicines (387 brands) show a general reduction in average prices due to market competition.

ğ—¡ğ—¶ğ—°ğ—µğ—² ğ— ğ—®ğ—¿ğ—¸ğ—²ğ˜ğ˜€:

Herbal medicines constitute only 1.62% of the total market share, indicating limited presence but potential growth opportunities in alternative medicines.

ğ—”ğ—»ğ˜ğ—¶ğ—ºğ—®ğ—¹ğ—®ğ—¿ğ—¶ğ—®ğ—¹ ğ——ğ—¿ğ˜‚ğ—´ ğ— ğ—®ğ—¿ğ—¸ğ—²ğ˜:

The analysis reveals 53 brands of antimalarial drugs produced by 23 manufacturers. Mefloquine stands out with only one competitor, suggesting limited market competition for this drug.

ğ—¥ğ—²ğ—´ğ—¶ğ—¼ğ—»ğ—®ğ—¹ ğ——ğ—¶ğ˜€ğ—½ğ—®ğ—¿ğ—¶ğ˜ğ—¶ğ—²ğ˜€:

There are significant variations in drug availability and pricing across different regions, with rural areas facing challenges such as limited supply and higher costs.

# ğ˜¾ğ’‰ğ™–ğ’ğ™¡ğ’†ğ™£ğ’ˆğ™šğ’”

ğ——ğ—®ğ˜ğ—® ğ—–ğ—¹ğ—²ğ—®ğ—»ğ—¶ğ—»ğ—´: Handling inconsistent dosage units (e.g., mg, mL, IU) and standardizing them for accurate analysis.

ğ—–ğ—¼ğ—ºğ—½ğ—¹ğ—²ğ˜… ğ—¥ğ—²ğ—¹ğ—®ğ˜ğ—¶ğ—¼ğ—»ğ˜€ğ—µğ—¶ğ—½ğ˜€: Mapping complex relationships between drug classes, generics, and manufacturers proved challenging due to missing values and incomplete data in some records.

ğ—¥ğ—²ğ—´ğ—¶ğ—¼ğ—»ğ—®ğ—¹ ğ——ğ—®ğ˜ğ—® ğ—šğ—®ğ—½ğ˜€: The dataset lacked granular regional data for rural markets, limiting the scope of the analysis in some areas.

# Conclusions

ğ—¦ğ˜ğ—¿ğ—®ğ˜ğ—²ğ—´ğ—¶ğ—° ğ—™ğ—¼ğ—°ğ˜‚ğ˜€ ğ—¼ğ—» ğ—–ğ—µğ—¿ğ—¼ğ—»ğ—¶ğ—° ğ—œğ—¹ğ—¹ğ—»ğ—²ğ˜€ğ˜€:
With chronic diseases like cardiovascular and diabetes being the primary focus of the generic medicine market, manufacturers should invest in expanding their offerings in these areas to meet growing demand.

ğ—–ğ—¼ğ—ºğ—½ğ—²ğ˜ğ—¶ğ˜ğ—¶ğ˜ƒğ—²ğ—»ğ—²ğ˜€ğ˜€ ğ—®ğ—»ğ—± ğ—£ğ—¿ğ—¶ğ—°ğ—¶ğ—»ğ—´:
The highly competitive nature of some drug segments, such as anti-hypertensives, leads to price reductions, making these medicines more affordable. This could be a model for other therapeutic areas with less competition.

ğ—¢ğ—½ğ—½ğ—¼ğ—¿ğ˜ğ˜‚ğ—»ğ—¶ğ˜ğ—¶ğ—²ğ˜€ ğ—³ğ—¼ğ—¿ ğ—šğ—¿ğ—¼ğ˜„ğ˜ğ—µ ğ—¶ğ—» ğ—›ğ—²ğ—¿ğ—¯ğ—®ğ—¹ ğ— ğ—²ğ—±ğ—¶ğ—°ğ—¶ğ—»ğ—²ğ˜€:
The herbal medicine market remains underdeveloped. Companies could tap into this niche by investing in alternative treatments and addressing the growing consumer interest in natural products.

ğ—˜ğ˜…ğ—½ğ—®ğ—»ğ—±ğ—¶ğ—»ğ—´ ğ—”ğ—°ğ—°ğ—²ğ˜€ğ˜€ ğ—¶ğ—» ğ—¥ğ˜‚ğ—¿ğ—®ğ—¹ ğ—”ğ—¿ğ—²ğ—®ğ˜€:
Pharmaceutical companies should explore opportunities to improve drug availability in rural regions, where logistics and supply chain challenges lead to limited access and higher prices.

ğ— ğ—®ğ—¿ğ—¸ğ—²ğ˜ ğ—£ğ—¼ğ˜ğ—²ğ—»ğ˜ğ—¶ğ—®ğ—¹ ğ—³ğ—¼ğ—¿ ğ—¡ğ—¶ğ—°ğ—µğ—² ğ——ğ—¿ğ˜‚ğ—´ğ˜€:
Drugs like Mefloquine, with minimal competition, present opportunities for manufacturers to expand their product lines in niche therapeutic categories.

![Screenshot 2024-10-04 160324](https://github.com/user-attachments/assets/7a4ef290-1197-4f7c-b932-42121b91e8d3)
